GemPharmatech Cash Flow Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	109.82	158.91	164.67	124.93
Depreciation & Amortization	83.74	53.73	39.07	28.81
Other Amortization	13.17	8.55	7.93	5.83
Loss (Gain) From Sale of Assets	-0.01	0.02	0.1	-
Asset Writedown & Restructuring Costs	-	-	-	14.08
Loss (Gain) From Sale of Investments	-10.35	-14.24	-9.44	-11.43
Provision & Write-off of Bad Debts	3.29	9.09	8.53	6.96
Other Operating Activities	18.93	20.14	11.48	1.21
Change in Accounts Receivable	-91.33	-87.52	-81.09	-73.31
Change in Inventory	-7.1	2.38	-19.39	-11.91
Change in Accounts Payable	-27.48	-23.85	-7.7	23.89
Change in Other Net Operating Assets	2.98	4.66	0.67	3.07
Operating Cash Flow	90.31	116.57	105.98	113.31
Operating Cash Flow Growth	-22.52%	9.99%	-6.47%	-12.69%
Capital Expenditures	-113.68	-205.9	-190.31	-89.07
Sale of Property, Plant & Equipment	-	0.11	0.11	-
Investment in Securities	259.21	176.24	-814.72	-275.19
Other Investing Activities	13.36	10.94	10.26	10.53
Investing Cash Flow	158.89	-18.61	-994.66	-353.73
Short-Term Debt Issued	97.95	86	11.99	-
Long-Term Debt Issued	-	-	-	25
Total Debt Issued	97.95	86	11.99	25
Short-Term Debt Repaid	-86	-21.99	-25	-
Long-Term Debt Repaid	-8.11	-6.42	-2.08	-10.71
Total Debt Repaid	-94.11	-28.42	-27.08	-10.71
Net Debt Issued (Repaid)	3.84	57.58	-15.09	14.29
Issuance of Common Stock	-	-	1,044	-
Repurchase of Common Stock	-32.67	-	-	-
Common Dividends Paid	-80.11	-17.87	-0.28	-0.68
Other Financing Activities	-	-0.43	-14.22	-3.39
Financing Cash Flow	-108.94	39.29	1,014	10.23
Foreign Exchange Rate Adjustments	0.96	1.15	2.63	-0.46
Net Cash Flow	141.22	138.4	128.08	-230.65
Free Cash Flow	-23.36	-89.33	-84.33	24.24
Free Cash Flow Margin	-3.40%	-14.36%	-16.33%	6.16%
Free Cash Flow Per Share	-0.06	-0.22	-0.21	0.07
Cash Income Tax Paid	40.59	3.44	3.17	27.32
Levered Free Cash Flow	-57.81	-75.74	-115.52	-35.41
Unlevered Free Cash Flow	-55.12	-74.01	-115.21	-34.95
Change in Working Capital	-128.27	-119.63	-116.35	-57.07

Source: S&P Global Market Intelligence. Standard template. Financial Sources.